Longitudinal diffusion MRI in PCNSL treated with methotrexate, rituximab, and temozolomide (MRT).

被引：0
|
作者：
Chandra, Vyshak
Ou, Yangming
Kalpathy-Cramer, Jayashree
Evans, John
Sprinkhuizen, Sara
Batchelor, Tracy
Gerstner, Elizabeth Robins
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Martinos Ctr Biomed Imaging, Charlestown, MA USA
[3] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.8579
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8579
引用
收藏
页数：1
相关论文
共 50 条
  • [1] High-Dose Methotrexate, Rituximab, and Temozolomide (MRT) for Patients with Primary CNS Lymphoma (PCNSL).
    Gerstner, Elizabeth R.
    Hochberg, Fred H.
    Plotkin, Scott R.
    Eichler, April F.
    Batchelor, Tracy T.
    BLOOD, 2009, 114 (22) : 667 - 667
  • [2] Methotrexate, Rituximab, Temozolomide (MRT) Induction Therapy for Elderly Patients with Primary Central Nervous System Lymphoma (PCNSL)
    Forst, Deborah
    Chi, Andrew
    Dietrich, Jorg
    Gerstner, Elizabeth
    Jones, SooAe
    Byrne, Thomas
    Hochberg, Fred
    Plotkin, Scott
    Batchelor, Tracy
    NEUROLOGY, 2013, 80
  • [3] Methotrexate, Rituximab, Temozolomide (MRT) Induction Therapy for Elderly Patients with Primary Central Nervous System Lymphoma (PCNSL)
    Forst, Deborah
    Chi, Andrew
    Dietrich, Jorg
    Gerstner, Elizabeth
    Jones, SooAe
    Byrne, Thomas
    Hochberg, Fred
    Plotkin, Scott
    Batchelor, Tracy
    NEUROLOGY, 2013, 80
  • [4] HIGH-DOSE METHOTREXATE, RITUXIMAB, AND TEMOZOLOMIDE (M/R/T) FOR PATIENTS WITH PRIMARY CNS LYMPHOMA (PCNSL)
    Gerstner, Elizabeth
    Hochberg, Fred
    Plotkin, Scott
    Eichler, April
    Batchelor, Tracy
    NEURO-ONCOLOGY, 2009, 11 (05) : 627 - 627
  • [5] Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly
    Fritsch, K.
    Kasenda, B.
    Hader, C.
    Nikkhah, G.
    Prinz, M.
    Haug, V.
    Haug, S.
    Ihorst, G.
    Finke, J.
    Illerhaus, G.
    ANNALS OF ONCOLOGY, 2011, 22 (09) : 2080 - 2085
  • [6] The pharmacokinetics of methotrexate with and without rituximab in the treatment of primary central nervous system lymphoma (PCNSL)
    Rawat, F. R.
    Nolan, A.
    Teo, S. Y.
    Triggs, M.
    Carroll, G.
    Picardo, S.
    Keegan, N. M.
    Mallett, V.
    Ismail, I.
    Hennessy, B.
    Grogan, W.
    Breathnach, O.
    Morris, P.
    ANNALS OF ONCOLOGY, 2016, 27
  • [7] Temozolomide (TMZ) and methotrexate (MTX) for initial treatment of primary central nervous system lymphoma (PCNSL)
    Omuro, AMP
    Taillandier, L
    Barrie, M
    Carnin, C
    Chinot, O
    Khe, HX
    NEUROLOGY, 2006, 66 (05) : A400 - A400
  • [8] Relapsed isolated CNS lymphoma treated with radiotherapy and intrathecal methotrexate followed by high-dose intravenous methotrexate, rituximab, and temozolomide: A case report
    Rinaldi, Ikhwan
    Muthalib, Abdul
    Gondhowiardjo, Soehartati
    Setiawan, Tjondro
    Gunawan, Andhika
    Susanto, Nelly
    Magdalena, Lingga
    Winston, Kevin
    Disamantiji, Ashila
    Wirawan, Bintang
    CLINICAL CASE REPORTS, 2024, 12 (03):
  • [9] Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT±MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Lable, Multicenter Clinical Trial
    Song, Jia
    Liu, Hui
    Jiao, Zongjiu
    Gao, Da
    Ding, Kai
    Wang, Yihao
    Yu, Hong
    Shao, Yuanyuan
    Jiang, Huijuan
    Gao, Shan
    Li, Lijuan
    Fu, Rong
    Shao, Zonghong
    BLOOD, 2022, 140 : 3739 - 3740
  • [10] Orelabrutinib, rituximab, temozolomide and high-dose methotrexate (RMOT) in newly diagnosed primary central nervous system lymphoma (PCNSL): A retrospective analysis on efficacy and safety.
    Xia, Yi
    Cai, Qingqing
    Zhang, Peng
    Tian, Xiaopeng
    Fang, Xiaojie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345